Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis-Reference-Cited by-同舟云学术

Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis

Published:2010-05 Issue:1-2 Volume:292 Page:28-35
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Radue Ernst-Wilhelm,Stuart William H.,Calabresi Peter A.,Confavreux Christian,Galetta Steven L.,Rudick Richard A.,Lublin Fred D.,Weinstock-Guttman Bianca,Wynn Daniel R.,Fisher Elizabeth,Papadopoulou Athina,Lynn Frances,Panzara Michael A.,Sandrock Alfred W.

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology

Reference49 articles.

1. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology;Brück;Ann Neurol,1997

2. Enhanced magnetic resonance imaging in multiple sclerosis;Filippi;Mult Scler,2000

3. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis;Katz;Ann Neurol,1993

4. Role of MRI in multiple sclerosis I: Inflammation and lesions;Zivadinov;Front Biosci,2004

5. Accumulation of hypointense lesions (“black holes”) on T1 spin-echo MRI correlates with disease progression in multiple sclerosis;Truyen;Neurology,1996

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of fingolimod on focal and diffuse damage in patients with relapsing–remitting multiple sclerosis – The “EVOLUTION” study;Journal of Neurology;2024-07-29

2. Toxicokinetics of a humanized anti-cocaine monoclonal antibody in male and female rats and lack of cross-reactivity;Human Vaccines & Immunotherapeutics;2023-11-08

3. Systematic review of gender bias in clinical trials of monoclonal antibodies for the treatment of multiple sclerosis;Neurología (English Edition);2023-11

4. α4 Integrins in Immune Homeostasis and Disease;Integrins in Health and Disease;2023

5. Monoclonal antibodies in multiple sclerosis treatment;Translational Neuroimmunology, Volume 8;2023